Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
6.22
-0.30 (-4.60%)
At close: Jul 2, 2024, 4:00 PM
6.39
+0.17 (2.73%)
After-hours: Jul 2, 2024, 7:31 PM EDT
Ironwood Pharmaceuticals Revenue
Ironwood Pharmaceuticals had revenue of $413.55M in the twelve months ending March 31, 2024, down -0.86% year-over-year. Revenue in the quarter ending March 31, 2024 was $74.88M, a -28.05% decrease year-over-year. In the year 2023, Ironwood Pharmaceuticals had annual revenue of $442.74M with 7.83% growth.
Revenue (ttm)
$413.55M
Revenue Growth
-0.86%
P/S Ratio
2.39
Revenue / Employee
$1,548,880
Employees
267
Market Cap
988.71M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 442.74M | 32.14M | 7.83% |
Dec 31, 2022 | 410.60M | -3.16M | -0.76% |
Dec 31, 2021 | 413.75M | 24.23M | 6.22% |
Dec 31, 2020 | 389.52M | -38.89M | -9.08% |
Dec 31, 2019 | 428.41M | 81.77M | 23.59% |
Dec 31, 2018 | 346.64M | 48.36M | 16.21% |
Dec 31, 2017 | 298.28M | 24.32M | 8.88% |
Dec 31, 2016 | 273.96M | 124.40M | 83.18% |
Dec 31, 2015 | 149.56M | 73.12M | 95.66% |
Dec 31, 2014 | 76.44M | 53.56M | 234.06% |
Dec 31, 2013 | 22.88M | -127.36M | -84.77% |
Dec 31, 2012 | 150.25M | 84.37M | 128.09% |
Dec 31, 2011 | 65.87M | 22.01M | 50.19% |
Dec 31, 2010 | 43.86M | 9.54M | 27.78% |
Dec 31, 2009 | 34.32M | 15.94M | 86.70% |
Dec 31, 2008 | 18.38M | 7.92M | 75.68% |
Dec 31, 2007 | 10.46M | 7.32M | 233.25% |
Dec 31, 2006 | 3.14M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Owens & Minor | 10.42B |
MiMedx Group | 334.51M |
Innoviva | 311.59M |
Maravai LifeSciences Holdings | 274.10M |
Gyre Therapeutics | 140.62M |
BioLife Solutions | 137.30M |
Simulations Plus | 64.67M |
IRWD News
- 4 days ago - The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation - Accesswire
- 6 days ago - The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue - Accesswire
- 7 days ago - The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact - Accesswire
- 8 days ago - The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication - Accesswire
- 9 days ago - The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect - Accesswire
- 10 days ago - The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out - Accesswire
- 13 days ago - Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact - Accesswire
- 14 days ago - Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out - Accesswire